Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs

Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs

July 13, 2026Posted inBiotechnology

Merck KGaA’s U.S. research site has instituted a new in-office work requirement that may lead to the imminent departure of as many as 70 staffers.

Post navigation

Previous Post
immune-evasion-uncovered-by-virome-wide-ubiquitin-ligase-discovery Immune Evasion Uncovered by Virome-Wide Ubiquitin Ligase Discovery
Next Post
Building a workforce engine for biomanufacturing

Recent Posts

  • Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
  • Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer
  • Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series
  • Representations of the intrinsic value of information in mouse orbitofrontal cortex
  • Pilot study to validate endothelium collection from pulmonary artery balloon catheter in children

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top